Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Government to ban...

    Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-07T11:00:48+05:30  |  Updated On 17 Aug 2021 12:08 PM IST

    New Delhi: Hyderabad based biotechnology firm, Bharat Biotech is likely to face setback as the Government plans to impose a ban on export of anti-rabies vaccine. According to a recent media report, in the wake of acute shortage of the drug across the country, the Government has proposed to ban the export of the vaccine, which is expected to be implemented shortly.


    "The health ministry has drawn a proposal, which has been sent to the law ministry for vetting. Once we get a go ahead from there, it will be notified," a senior official confirmed to TOI.


    It is learnt through the media report that though there are around five vaccine manufacturers in the country, however, 20-80% shortage in anti-rabies vaccines is witnessed in almost all states.


    Besides Bharat Biotech, there exist other vaccine manufacturers in the country including major drug makers like Serum Institute and Indian Immunologicals.


    The ban, if imposed, would greatly quake the business of Bharat Biotech as the company had recently announced the acquisition of Chiron Behring Vaccines Pvt Ltd, a move that would make Bharat Biotech the world's largest maker of rabies vaccines.


    Also Read: Bharat Biotech acquires GSK Indian arm that produces anti-rabies vaccine


    According to the World Health Organisation (WHO), India accounts for 36% of rabies deaths that occur worldwide each year. While one can develop the disease if bitten or scratched by any rabid mammal, such as a monkey or a bat, WHO says dogs contribute up to 99% of all rabies transmitted to humans; and children are the usual victims.


    Government estimates show the five companies together manufacture 50 million doses of anti-rabies vaccine in India against yearly demand of 48 million. Sadly, more than 30% of the production is exported to countries across the world where they fetch a higher price.


    However, many dispensaries and Government hospitals across the country have been facing an acute dearth of anti-rabies vaccine for almost a year now.


    "The vaccine is not even easily available in the open market. We have raised the issue with the government's central procurement agency, but even it has not received the supply," doctors from central as well as Delhi government hospitals told TOI.


    In fact, the situation has turned so grave that a recent tender for government procurement of the vaccine by the Delhi Government did not receive participation from any of the companies.


    Providing treatment to the victims, within 10 days of infection, is considered an effective way of protecting people. However, the shortage of anti-rabies vaccine has raised concerns among both the medical fraternity as well as the government.


    In the Indian market, the vaccine costs around Rs 300 while it is provided free of cost in government hospitals.

    antirabies vaccineBharat BiotechDelhi governmentexportexport of druggovt hospitalhealthhealth newsHealthcareHealthcare NewsIndiamammalmedicinemedicinesrabiesrabies deathvaccineWHOWorld Health Organization
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok